p300 Protects VRK1 and VRK2 from p53-Induced Downregulation
Author Information
Author(s): Alberto Valbuena, Sandra Vega, Francisco M. Lazo, Pedro A. Lazo
Primary Institution: Instituto de Biología Molecular y Celular del Cáncer, Centro de Investigación del Cáncer, Consejo Superior de Investigaciones Científicas (CSIC)-Universidad de Salamanca, Salamanca, Spain
Hypothesis
The study investigates how different p53 transcriptional cofactors affect the downregulation of VRK1 and VRK2 proteins.
Conclusion
The downregulation of VRK1 and VRK2 by p53 is dependent on the availability of transcriptional cofactors like p300 and CBP.
Supporting Evidence
- p300 and CBP were shown to prevent VRK1 downregulation induced by p53.
- PCAF did not protect VRK1 from downregulation by p53.
- The protective effect of p300 was independent of its acetyltransferase activity.
- Mutations in p53 that affect its transcriptional activity also influenced VRK1 levels.
Takeaway
This study shows that certain proteins can help protect other proteins from being broken down by p53, which is important for cell health.
Methodology
The study used biochemical characterization and transfection experiments in H1299 cells to analyze the effects of p53 and its cofactors on VRK1 and VRK2.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website